The reason why SynoviCre for dogs was discontinued is because the company that distributes the product, Teva Animal Health, located in St. Joseph, Missouri, was charged with violating numerous 'Good Manufacturing Practices' established by the Food and Drug Administration during the past few years. The FDA filed an injunction on July 31, 2009 that shut down plant operations until its facilities meet or exceed current 'Good Manufacturing Practices' standards, as certified by an independent expert and subsequently approved by the FDA.
Good manufacturing practice standards establish product quality and are the most relied on instrument used by the FDA to assure that veterinary drug and supplement products are both safe and effective.
Teva Pharmaceutical Industries, Ltd., headquartered in Israel, has branches around the world. The company specializes in human and animal grade pharmaceuticals. They are the parent company of Teva Animal Health, the distributor of SynoviCre, a private label joint supplement product.